Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03519308
Title A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Micoenvironment in Resectable Pancreatic Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Abramson Cancer Center of the University of Pennsylvania

pancreatic adenocarcinoma


Gemcitabine + Nab-paclitaxel + Nivolumab + Paricalcitol

Gemcitabine + Nab-paclitaxel + Nivolumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.